Literature DB >> 11006967

Chronic repetitive transcranial magnetic stimulation induces subsensitivity of presynaptic serotonergic autoreceptor activity in rat brain.

E Gur1, B Lerer, E Dremencov, M E Newman.   

Abstract

Repetitive transcranial magnetic stimulation (rTMS) is a novel procedure which has proven effective in the treatment of major depression. We administered rTMS chronically to rats in order to determine whether this procedure affected serotonergic neurotransmission in the prefrontal cortex. Basal 5-HT levels, and the effects of challenges with the 5-HT1A receptor agonist 8-OH-DPAT and the 5-HT1B antagonist GR 127935 on 5-HT levels were determined using in vivo microdialysis. Rats which had undergone chronic rTMS showed reduced responses to both challenges, indicating subsensitivity of both the presynaptic 5-HT1A autoreceptors situated somatodendritically in the raphe nuclei and the 5-HT1B autoreceptors situated on nerve terminals. Since such subsensitivity has been demonstrated after other antidepressant treatments, our results indicate that these treatments and rTMS may have a common mechanism of action.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11006967     DOI: 10.1097/00001756-200009110-00019

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  12 in total

1.  [Vagus nerve stimulation, repetitive transcranial magnetic stimulation, and electroconvulsive therapy in the treatment of depressive disorders].

Authors:  M Bajbouj; I Heuser
Journal:  Nervenarzt       Date:  2005-01       Impact factor: 1.214

Review 2.  The role of serotonin receptor subtypes in treating depression: a review of animal studies.

Authors:  Gregory V Carr; Irwin Lucki
Journal:  Psychopharmacology (Berl)       Date:  2010-11-24       Impact factor: 4.530

3.  Higher serotonin 1A binding in a second major depression cohort: modeling and reference region considerations.

Authors:  Ramin V Parsey; R Todd Ogden; Jeffrey M Miller; Adrienne Tin; Natalie Hesselgrave; Ellen Goldstein; Arthur Mikhno; Matthew Milak; Francesca Zanderigo; Gregory M Sullivan; Maria A Oquendo; J John Mann
Journal:  Biol Psychiatry       Date:  2010-05-23       Impact factor: 13.382

Review 4.  Repetitive transcranial magnetic stimulation : does it have potential in the treatment of depression?

Authors:  Frank Padberg; Hans-Jürgen Möller
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

5.  SSRI response in depression may be influenced by SNPs in HTR1B and HTR1A.

Authors:  Sandra M Villafuerte; Kamala Vallabhaneni; Elzbieta Sliwerska; Francis J McMahon; Elizabeth A Young; Margit Burmeister
Journal:  Psychiatr Genet       Date:  2009-12       Impact factor: 2.458

Review 6.  Translational neuromodulation: approximating human transcranial magnetic stimulation protocols in rats.

Authors:  Andrew M Vahabzadeh-Hagh; Paul A Muller; Roman Gersner; Abraham Zangen; Alexander Rotenberg
Journal:  Neuromodulation       Date:  2012-07-10

Review 7.  Nonpharmacological, somatic treatments of depression: electroconvulsive therapy and novel brain stimulation modalities.

Authors:  Renana Eitan; Bernard Lerer
Journal:  Dialogues Clin Neurosci       Date:  2006       Impact factor: 5.986

8.  Personalized TMS: role of RNA genotyping.

Authors:  Shawna Chan; Robert Bota
Journal:  Ment Illn       Date:  2019-11-04

9.  Dorsolateral prefrontal transcranial magnetic stimulation in patients with major depression locally affects alpha power of REM sleep.

Authors:  Maria Concetta Pellicciari; Susanna Cordone; Cristina Marzano; Stefano Bignotti; Anna Gazzoli; Carlo Miniussi; Luigi De Gennaro
Journal:  Front Hum Neurosci       Date:  2013-08-02       Impact factor: 3.169

Review 10.  The 5-HT1B receptor - a potential target for antidepressant treatment.

Authors:  Mikael Tiger; Katarina Varnäs; Yoshiro Okubo; Johan Lundberg
Journal:  Psychopharmacology (Berl)       Date:  2018-03-15       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.